Company Active LTD

Company profile

Proxximos Limited

Home - Proxximos

Proxximos Limited is a UK company with status active founded in 2021 based in South West England.

CRN
13516077
Founded
2021
Age
4

Overview

Legal name
PL 123 (SW) LIMITED
Region
South West England
Registered address
SUITE B, BLACKDOWN HOUSE
BLACKBROOK PARK AVENUE
TAUNTON
SOMERSET
TA1 2PX
Insolvency history
No

Corporate ownership

Updated 07 Jul 2026 09:49

1 level 1 ultimate controller
1
Company Active LTD
Proxximos Limited
CRN 13516077
2
Direct and ultimate controller Active LTD

Company events

Reference milestones and recent Companies House filing stream events.

9 events
30 Apr
2026

Accounts due

Accounts Due

Next accounts due date

10 Nov
2025

Confirmation statement due

Confirmation Due

Next confirmation statement due date

27 Oct
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQ0MTA1MDc5NmFkaXF6a2N4

Published 27 Oct 2024 03:24

27 Oct
2024

Confirmation statement filed

Confirmation

Last confirmation statement made up date

03 Oct
2024

Accounts With Accounts Type Micro Entity

Accounts Awaiting analysis

AA | Transaction MzQzODI5ODgwOGFkaXF6a2N4

Published 03 Oct 2024 12:22

21 Sep
2024

Cessation Of A Person With Significant Control

Persons-with-significant-control

PSC07 | Transaction MzQzNjc1OTI5NGFkaXF6a2N4

Published 21 Sep 2024 09:19

21 Sep
2024

Termination Director Company With Name Termination Date

Officers

TM01 | Transaction MzQzNjc1OTE5MmFkaXF6a2N4

Published 21 Sep 2024 09:15

31 Jul
2024

Accounts filed

Accounts

Last accounts made up date

16 Jul
2021

Incorporated

Inception

Company registered at Companies House

Public funding

1 award
First funded
2023
Funded years
2023
Age at first award
1 years

Projects

2023 Collaborative R&D Lead participant

Trial of innovative digital infection control solution in Manchester NHS FT ICU

1 Apr 2023 to 31 Mar 2024

Awarded
£233,897
Total cost £334,139

Our innovative solution is designed to prevent Healthcare Acquired Infections (HCAIs) from spreading around hospitals. The objective of this project is to investigate the solution in the ICU in the Manchester University NHS Foundation Trust (MFT) -- our collaboration partner. This will enable us to develop the solution, certify it and then market it to he...

Product types

Collaborative R&D